Literature DB >> 23218580

Do we have a future with transcatheter adventitial delivery of stem cells?

Alexander N Kharlamov, Henricus J Duckers, Heleen M M van Beusekom, Pieter C Smits, Emerson C Perin, Patrick W Serruys.   

Abstract

Critically evaluating the methodology of the adventitial delivery of stem cells, some specific options should be underlined. Adventitia as the most superficial layer, consisting of connective tissue has to be distinguished of perivascular tissues. By strict definition, an adventitia is the outermost connective tissue covering any organ, or vessel. The "adventitial" delivery of stem cells with a 1mm micro-needle means a delivery to superficial so called pericardial myocardium, perivascular fat tissues, including a risk of perforation and injury of soft tissues. In fact, the mapping of the artery with visualization of the three-layer vessel structure and perivascular tissues as well as pericardial space with the state-of-the-art imaging approaches including IVUS (intravascular ultrasound) or OCT (optical coherence tomography) allows to find an optimal site for injection, prevents any technical complications and improves efficacy. NOGA magnetic navigation system still remains the optimal tool for the stem cell delivery to myocardium with appropriate visualization of necrosis and peri-infarct tissues. Potentially, more advanced imaging provides a chance to deliver infusate to the adventitial layer, which is a gate to the vessel wall for inflammation as well as a source of stem and progenitor cells, and myofibroblasts.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23218580     DOI: 10.1016/j.ijcard.2012.11.063

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Rationale and design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (the POSEIDON-DCM study): a phase I/II, randomized pilot study of the comparative safety and efficacy of transendocardial injection of autologous mesenchymal stem cell vs. allogeneic mesenchymal stem cells in patients with non-ischemic dilated cardiomyopathy.

Authors:  Muzammil Mushtaq; Darcy L DiFede; Samuel Golpanian; Aisha Khan; Samirah A Gomes; Adam Mendizabal; Alan W Heldman; Joshua M Hare
Journal:  J Cardiovasc Transl Res       Date:  2014-10-30       Impact factor: 4.132

2.  Features of atherosclerosis in the tunica adventitia of coronary and carotid arteries in a black kenyan population.

Authors:  Julius Ogeng'o; Kevin Ongeti; Moses Obimbo; Beda Olabu; Philip Mwachaka
Journal:  Anat Res Int       Date:  2014-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.